2022
DOI: 10.1371/journal.pone.0271049
|View full text |Cite
|
Sign up to set email alerts
|

The impact of the Covid-19 pandemic on the incidence of diseases and the provision of primary care: A registry-based study

Abstract: Introduction The Covid-19 pandemic had a tremendous impact on healthcare but uncertainty remains about the extent to which primary care provision was affected. Therefore, this paper aims to assess the impact on primary care provision and the evolution of the incidence of disease during the first year of the Covid-19 pandemic in Flanders (Belgium). Methods Care provision was defined as the number of new entries added to a patient’s medical history. Pre-pandemic care provision (February 1, 2018–January 31, 202… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 21 publications
(11 citation statements)
references
References 34 publications
1
10
0
Order By: Relevance
“…This interpretation is further supported by the fact that, in 2022, there was a previously unprecedented peak in incidence, which can probably be attributed not only to the incidence of new MG cases, but also to the diagnoses that had not been made in the previous two years. For example, the group of Van den Bulck [ 56 ] observed that, following the pandemic, the incidence of chronic diseases in Flanders decreased and returned to baseline values at the end of the emergency, and this could also be the case for the changes observed by our group. Despite these considerable limitations, interestingly, the prevalence of non-thymoma MG and LOMG is also confirmed in this period; they are significantly more frequent than thymoma MG cases ( n = 2, 6.9% of new cases in the period) and EOMG ( n = 1, 3.4% of new cases in the period).…”
Section: Discussionsupporting
confidence: 66%
“…This interpretation is further supported by the fact that, in 2022, there was a previously unprecedented peak in incidence, which can probably be attributed not only to the incidence of new MG cases, but also to the diagnoses that had not been made in the previous two years. For example, the group of Van den Bulck [ 56 ] observed that, following the pandemic, the incidence of chronic diseases in Flanders decreased and returned to baseline values at the end of the emergency, and this could also be the case for the changes observed by our group. Despite these considerable limitations, interestingly, the prevalence of non-thymoma MG and LOMG is also confirmed in this period; they are significantly more frequent than thymoma MG cases ( n = 2, 6.9% of new cases in the period) and EOMG ( n = 1, 3.4% of new cases in the period).…”
Section: Discussionsupporting
confidence: 66%
“…COVID-19 was prioritised in all countries and developments in the eld of chronic care were halted or pushed back. International research (29), as well as country-speci c reports (30,31) support the nding that care for patients with chronic diseases was substantially affected during the pandemic.…”
Section: Discussionmentioning
confidence: 95%
“…Additionally, addressing concerns from patients about accessing healthcare during a pandemic is crucial, and effective risk communication strategies and infection control measures should be implemented in healthcare settings. Risk communication can inform and educate patients about the benefits and risks of seeking care, the availability and accessibility of services, and the safety protocols in place to prevent COVID-19 transmission [ 53 ]. Infection control measures can include screening, triage, isolation, personal protective equipment, ventilation, and disinfection [ 51 , 54 ].…”
Section: Discussionmentioning
confidence: 99%